Allay Therapeutics’ Post

What does it take to build a thriving medtech venture? 🤔 In our latest ClavystBio Conversations co-hosted with National Health Innovation Centre (NHIC), we explored this question with industry leaders: Lightstone Ventures' Mike Carusi and Allay Therapeutics' Koon Kiat Teu. Moderated by ClavystBio Medtech Director Yingmin Wang, they shared key insights from Allay’s inspiring journey, including the early days of Orchid Medical, Allay’s pivot to non-opioid pain management and its successful Phase IIB clinical trial results. 𝗞𝗲𝘆 𝘁𝗮𝗸𝗲𝗮𝘄𝗮𝘆𝘀 𝗳𝗿𝗼𝗺 𝘁𝗵𝗲 𝗱𝗶𝘀𝗰𝘂𝘀𝘀𝗶𝗼𝗻: 📌 𝗣𝗮𝘁𝗶𝗲𝗻𝘁-𝗰𝗲𝗻𝘁𝗿𝗶𝗰𝗶𝘁𝘆 𝗶𝘀 𝗣𝗮𝗿𝗮𝗺𝗼𝘂𝗻𝘁: Make patients the NorthStar of your endeavors. 📌 𝗙𝗼𝗰𝘂𝘀 𝗼𝗻 𝗨𝗻𝗺𝗲𝘁 𝗡𝗲𝗲𝗱𝘀: Start with the commercial opportunity, and find the right technology to fit. 📌 𝗖𝗼𝗻𝘀𝗶𝗱𝗲𝗿 𝗥𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆 𝗮𝗻𝗱 𝗥𝗲𝗶𝗺𝗯𝘂𝗿𝘀𝗲𝗺𝗲𝗻𝘁 𝗘𝗮𝗿𝗹𝘆 𝗼𝗻: Think about downstream implications when developing ideas. 📌 𝗧𝗲𝗻𝗮𝗰𝗶𝘁𝘆 𝗶𝘀 𝗞𝗲𝘆: Listen, learn, and iterate. Embrace feedback from investors and adapt as needed. Stay tuned for our video of the conversation soon! 🎥 #MedTech #VentureBuilding #Innovation #AllayTherapeutics #LightstoneVentures #NHIC #ClavystBio